Follow
Albert AlÚ
Albert AlÚ
PhD
No verified email
Title
Cited by
Cited by
Year
Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice
J Bruna, E Udina, A AlÚ, JJ Vilches, A Vynckier, J Monbaliu, L Silverman, ...
Experimental neurology 223 (2), 599-608, 2010
1152010
Neurotoxicity induced by antineoplastic proteasome inhibitors
A Ale, J Bruna, X Navarro, E Udina
Neurotoxicology 43, 28-35, 2014
592014
Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model
A AlÚ, J Bruna, M Morell, H van de Velde, J Monbaliu, X Navarro, E Udina
Experimental neurology 253, 165-173, 2014
512014
Differential effects on KCC2 expression and spasticity of ALS and traumatic injuries to motoneurons
L M˛dol, R Mancuso, A AlÚ, I Francos-Quijorna, X Navarro
Frontiers in cellular neuroscience 8, 7, 2014
392014
Toxic effects of bortezomib on primary sensory neurons and Schwann cells of adult mice
A AlÚ, J Bruna, M Herrando, X Navarro, E Udina
Neurotoxicity Research 27, 430-440, 2015
372015
Substratum preferences of motor and sensory neurons in postnatal and adult rats
F Gonzalez‐Perez, A AlÚ, D Santos, C Barwig, T Freier, X Navarro, ...
European Journal of Neuroscience 43 (3), 431-442, 2016
312016
Inhibition of the neuronal NFκB pathway attenuates bortezomib-induced neuropathy in a mouse model
A AlÚ, J Bruna, A Calls, M Karamita, S Haralambous, L Probert, X Navarro, ...
Neurotoxicology 55, 58-64, 2016
292016
Central leptin and tumor necrosis factor-α (TNFα) in diurnal control of blood pressure and hypertension
C Han, W Wu, A Ale, MS Kim, D Cai
Journal of Biological Chemistry 291 (29), 15131-15142, 2016
272016
Evaluation of pre‐existing neuropathy and bortezomib retreatment as risk factors to develop severe neuropathy in a mouse model
J Bruna, A AlÚ, R Velasco, J Jaramillo, X Navarro, E Udina
Journal of the Peripheral Nervous System 16 (3), 199-212, 2011
212011
Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase
A AlÚ, Y Zhang, C Han, D Cai
American Journal of Physiology-Endocrinology and Metabolism 312 (3), E161-E174, 2017
132017
Sphingolipid metabolism products: potential new players in the pathogenesis of bortezomib-induced neuropathic pain
A AlÚ, AA Argyriou, J Bruna
Annals of Translational Medicine 6 (Suppl 1), 2018
22018
SERUM LEVELS OF VITAMIN E AND NERVE GROWTH FACTOR IN PATIENTS DEVELOPING CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
R Velasco, M Simˇ, C Santos, M Gil, R Salazar, M Galan, R Palmero, ...
Neuro-Oncology 14, 81-81, 2012
12012
Metabolic Control by Inflammation and Immunity: Obesity-associated extracellular mtDNA activates central TGFβ pathway to cause blood pressure increase
A AlÚ, Y Zhang, C Han, D Cai
American Journal of Physiology-Endocrinology and Metabolism 312 (3), E161, 2017
2017
Obesity-associated extracellular mtDNA activates central TGFβ pathway 2
A AlÚ, Y Zhang, C Han, D Cai
2016
The system can't perform the operation now. Try again later.
Articles 1–14